LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 513 | 6501 | 10401 | 0.6250 | 0.6056 |
MCF 10A | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 513 | 8387 | 10401 | 0.8064 | 0.7963 |
MCF 10A | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 513 | 6249 | 10401 | 0.6009 | 0.5801 |
MCF 10A | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 10440 | 10401 | 1.0037 | 1.0039 |
MCF 10A | JNK-9L | 0.12 | uM | LJP6 | 72 | hr | 513 | 7616 | 10401 | 0.7322 | 0.7183 |
MCF 10A | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 513 | 9173 | 10401 | 0.8820 | 0.8759 |
MCF 10A | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 8925 | 10401 | 0.8581 | 0.8508 |
MCF 10A | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 513 | 9904 | 10401 | 0.9523 | 0.9498 |
MCF 10A | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 513 | 11112 | 10401 | 1.0684 | 1.0720 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 7087 | 10401 | 0.6814 | 0.6649 |
MCF 10A | Mitoxantrone | 0.12 | uM | LJP5 | 72 | hr | 513 | 662 | 10401 | 0.0637 | 0.0151 |
MCF 10A | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 513 | 690 | 10401 | 0.0663 | 0.0179 |
MCF 10A | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 513 | 9837 | 10401 | 0.9458 | 0.9430 |
MCF 10A | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 766 | 10401 | 0.0737 | 0.0256 |
MCF 10A | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 10609 | 10401 | 1.0200 | 1.0210 |
MCF 10A | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 513 | 10367 | 10401 | 0.9968 | 0.9966 |
MCF 10A | NU7441 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10405 | 10401 | 1.0004 | 1.0004 |
MCF 10A | Dactolisib | 0.12 | uM | LJP5 | 72 | hr | 513 | 1514 | 10401 | 0.1456 | 0.1013 |
MCF 10A | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 513 | 3340 | 10401 | 0.3212 | 0.2859 |
MCF 10A | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 513 | 6252 | 10401 | 0.6011 | 0.5804 |
MCF 10A | PD0325901 | 0.12 | uM | LJP5 | 72 | hr | 513 | 842 | 10401 | 0.0810 | 0.0333 |
MCF 10A | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 513 | 687 | 10401 | 0.0661 | 0.0176 |
MCF 10A | PD173074 | 0.12 | uM | LJP6 | 72 | hr | 513 | 10571 | 10401 | 1.0163 | 1.0172 |
MCF 10A | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 513 | 2900 | 10401 | 0.2789 | 0.2414 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 811 | 10401 | 0.0780 | 0.0302 |